U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Meperidine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 05/30/2025
»Therapeutic Categories: Analgesia/Addiction

Expand all

Hikma Pharmaceuticals USA, Inc. (Reverified 10/14/2026)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Hospira, Inc., a Pfizer Company (Reverified 10/08/2026)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) Available
Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) Available
Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) Available
Back to Top